Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius Sells 22 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 22 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $510.79, for a total value of $11,237.38. Following the completion of the transaction, the senior vice president now owns 229 shares of the company’s stock, valued at approximately $116,970.91. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Mark Brosius also recently made the following trade(s):

• On Tuesday, October 22nd, Mark Brosius sold 2,128 shares of Intuitive Surgical stock. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00.
• On Thursday, September 12th, Mark Brosius sold 2,115 shares of Intuitive Surgical stock. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65.

Intuitive Surgical Trading Down 0.2 %

NASDAQ:ISRG traded down $0.95 during midday trading on Thursday, hitting $511.63. 755,379 shares of the stock were exchanged, compared to its average volume of 1,471,841. The company has a market capitalization of $181.48 billion, a price-to-earnings ratio of 92.35, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $523.34. The business has a 50-day moving average price of $486.71 and a two-hundred day moving average price of $440.96.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Citigroup lifted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Mizuho boosted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Leerink Partners boosted their price objective on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. BTIG Research set a $535.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Finally, JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter valued at $26,000. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. Creekmur Asset Management LLC boosted its holdings in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. LGT Financial Advisors LLC boosted its holdings in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares in the last quarter. Finally, Delos Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.